Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Luxfer to Report 2018 Third Quarter Results on October 31 and Host Conference Call on November 1
-
XBiotech (XBIT) Reports Complete Enrollment in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Atopic Dermatitis
-
Stanford Releases Annual Financial Results for Investment Return, Endowment
-
Burlington Stores (BURL) Appoints Jessica Rodriguez to Board
-
Republic Services (RSG) Names Katharine Weymouth to Board
-
TG Therapeutics (TGTX) Said Final Phase 2 MS Data Selected for Oral Presentation at ECTRIMS
-
Canadian Pacific Railway (CP) appoints Edward Monser to its Board of Directors
-
Syndax Pharmaceuticals (SNDX) Appoints Jennifer Jarrett and William Meury to Board Succeeding Luke Evnin Ph.D. and Henry Chen
-
QS Global MBA & Business Masters Rankings 2019
-
SAP Becomes First European Tech Company to Create Ethics Advisory Panel for Artificial Intelligence
-
Nintendo Partners with the Tailgate Tour to Bring Super Smash Bros. Ultimate to Colleges This Fall
-
Stanford University, PACE to release Getting Down To Facts II Report on California PreK-12 Education
-
Amicus Therapeutics (FOLD) Appoints Lynn D. Bleil to Board
-
Franklin Resources (BEN) Enters JV Partnership with Asia Alternatives to Launch Franklin Templeton Private Equity
-
KKR & Co. (KKR) Announces Mary Dillon to Board
-
MYnd Analytics Inc. (MYND) Announces Publication Highlighting Positive Economic Impact to Payors from PEER Utilization
-
Vainu Labs Builds A.I. to Read and to Understand What Is Being Said About Companies on the Web
-
The future of surgery has arrived in a newly opened center at Lucile Packard Children's Hospital Stanford
-
Avnet (AVT) Appoints Jo Ann Jenkins to Board
-
Dynavax (DVAX) Reports Publication of Two Papers in Leading Oncology Journal Highlighting Data From Clinical Studies of Its TLR9 Agonist, SD-101
-
Form MA-I/A Southwest Stanford Group
-
Immunovative, Inc. (IMUN) Appoints Gary Blick MD to Scientific Advisory Board
-
Stanford Graduate School of Business Announces 2018-2019 Recipients of Stanford USA MBA Fellowship
-
Brownlee Brothers Set To Compete In 2018 Beijing International Triathlon With A Field Of 30 Professional Triathletes
-
Glen Burnie Bancorp (GLBZ) Names Joan Rumenap and Stanford Hess to Board of Directors
-
Gilead Sciences (GILD) Chief Medical Officer Andrew Cheng to Leave
-
YogaWorks (YOGA) Names Sky Meltzer to Board of Directors
-
Nine Energy Services (NINE) Names Darryl Willis to Board
-
Precipio (PRPO) Announces Kathleen LaPorte to Board
-
Ally Financial (ALLY) Names Brian Sharples and Trynka Shineman to Board
-
TG Therapeutics (TGTX) Reports Complete Target Enrollment in ULTIMATE Phase 3 Trials in Multiple Sclerosis
-
First Hawaiian (FHB) Names Faye W. Kurren and Jenai S. Wall to Board
-
Heartland Financial (HTLF) Appoints Susan G. Murphy to Board
-
Energizer Holdings (ENR) Names Nneka L. Rimmer To Board
-
Olin Corp. (OLN) Declares $0.20 Quarterly Dividend, 2.8% Yield; Appoints Stephanie A. Streeter to Board
-
Soligenix, Inc. (SNGX) Appoints Mark Pearson to Board
-
Flotek Industries (FTK) Announces Kate Richard to Board
-
EyePoint Pharmaceuticals (EYPT) Announces Data Highlighting YUTIQ for Posterior Segment Uveitis to be Presented at ASRS
-
Stanford Nephrology Fellow Katherine M. Wang Named American Kidney Fund Clinical Scientist in Nephrology
-
Stanford Nephrology Fellow Katherine M. Wang Named American Kidney Fund Clinical Scientist in Nephrology
-
Stephen Luczo joins Board of Directors at Lucile Packard Children's Hospital Stanford
-
Marvell Technology (MRVL) Completes Acquisition of Cavium (CAVM)
-
Luxfer to Report 2018 Second Quarter Results on August 1 and Host Conference Call on August 2
-
Luxfer Declares Quarterly Dividend
-
Endologix (ELGX) Reports Positive 1-Year Results from Ovation LUCY Study
-
Jazz Pharmaceuticals (JAZZ) Announces FDA Acceptance of sNDA for Xyrem to Treat Cataplexy and Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients
-
Simulations Plus (SLP) Names Shawn O'Connor as CEO
-
Shaping the Way towards Sustainable Mobility with Virtual Prototyping
-
CryoLife (CRY) Appoints Marna Borgstrom to Board
-
TG Therapeutics (TGTX) Reports Updated Results from Ongoing Phase 2 Study of Ublituximab in Patients with Multiple Sclerosis

